Fourth Circuit Shines Light on Company Doe – Litigation Record Ordered Unsealed

Participate in a short  Post-Company Doe Survey and receive $200 off to register for ACI’s 2nd Annual Summit on Consumer Products Regulation & Litigation .  Offer expires May 16th, 2014.  To take the survey click here. by Chris Soverow, Conference Producer at ACI On April 16, 2014, the Fourth Circuit issued a landmark decision ordering that…

Supreme Court Takes Case About Company Stock Funds and Presumption of Prudence

Expert Guest Entry by Wilber H. Boies , PC, Prashant Kolluri, Nancy G. Ross, Chris C. Scheithauer & Michael S. Yellin, Originally Published on http://www.mwe.com  The Supreme Court of the United States granted certiorari in Fifth Third Bancorp v. Dudenhoeffer, suggesting that the Supreme Court will resolve the current division among U.S. circuit courts regarding the application of the “presumption of prudence”…

Pharmaceutical Product Switching: Antitrust Pitfalls

Expert Guest Entry by Paul Ragusa, Originally published on Law 360 The terms “product switching,” “product hopping” and “line extension” are often used to describe the strategy of protecting market share by reformulating or otherwise modifying an existing branded pharmaceutical product in a manner which requires approval from the U.S. Food and Drug Administration. Under this…